Literature DB >> 29129440

Bosutinib more effective than imatinib in CML.

Elizabeth Gourd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29129440     DOI： 10.1016/S1470-2045(17)30840-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  LINCS gene expression signature analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting eIF4G1.

Authors:  Sai Hu; Dafei Xie; Pingkun Zhou; Xiaodan Liu; Xiaoyao Yin; Bo Huang; Hua Guan
Journal:  Int J Mol Med       Date:  2021-03-11       Impact factor: 4.101

2.  Bosutinib-associated interstitial lung disease and pleural effusion: A case report and literature review.

Authors:  Qiuying Selina Liu; Nour Ali Ass'ad; Cecilia Arana Yi
Journal:  Clin Case Rep       Date:  2021-05-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.